Influence of raltegravir intensification on viral load and 2-LTR dynamics in HIV patients on suppressive antiretroviral therapy
From MaRDI portal
Publication:2013422
DOI10.1016/J.JTBI.2016.12.015zbMATH Open1368.92105OpenAlexW2561775660WikidataQ39063587 ScholiaQ39063587MaRDI QIDQ2013422FDOQ2013422
Authors: Xia Wang, Gregory Mink, Xinyu Song, Libin Rong, Daniel W. Lin 
Publication date: 18 August 2017
Published in: Journal of Theoretical Biology (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/j.jtbi.2016.12.015
Recommendations
- Viral dynamic model of antiretroviral therapy including the integrase inhibitor raltegravir in patients with HIV-1
- Complex patterns of viral load decay under antiretroviral therapy: influence of pharmacokinetics and intracellular delay
- Spatial modeling of HIV cryptic viremia and 2-LTR formation during raltegravir intensification
- Modelling of HIV viral load and 2-LTR dynamics during high active antiretroviral therapy in a heterogeneous environment
- Dynamic treatment model to examine the association between phenotypic drug resistance and duration of HIV viral suppression
- Effects of combined drug therapy on HIV-1 infection dynamics
- Impact of combined therapy in HIV-1 treatment: a double impulsive approach
- HIV-1 dynamics at different time scales under antiretroviral therapy
- A drug pharmacodynamics and pharmacokinetics based approach towards stabilization of HIV infection dynamics
- Optimal controls of the highly active antiretroviral therapy
Medical applications (general) (92C50) Medical epidemiology (92C60) Lyapunov and storage functions (93D30)
Cites Work
- Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission
- HIV-1 infection and low steady state viral loads
- Modeling HIV persistence, the latent reservoir, and viral blips
- Viral Dynamic Model of Antiretroviral Therapy Including the Integrase Inhibitor Raltegravir in Patients with HIV-1
- Asymmetric division of activated latently infected cells may explain the decay kinetics of the HIV-1 latent reservoir and intermittent viral blips
- Dynamics of an HIV model with multiple infection stages and treatment with different drug classes
- Mathematical Analysis of Age‐Structured HIV‐1 Dynamics with Combination Antiretroviral Therapy
- Spatial modeling of HIV cryptic viremia and 2-LTR formation during raltegravir intensification
Cited In (17)
- Stationary distribution and extinction of a multi-stage HIV model with nonlinear stochastic perturbation
- Retention of antigen on follicular dendritic cells and B lymphocytes through complement-mediated multivalent ligand-receptor interactions: theory and application to HIV treatment
- Analysis of HIV latent infection model with multiple infection stages and different drug classes
- HIV infection dynamics and viral rebound: modeling results from humanized mice
- Title not available (Why is that?)
- Propagation dynamics for a spatial discrete virus model with HIV viral load and 2-LTR dynamics
- Dynamics of a new HIV model with the activation status of infected cells
- An HIV model with age-structured latently infected cells
- The effects of CTL immune response on HIV infection model with potent therapy, latently infected cells and cell-to-cell viral transmission
- Dynamics of an HIV infection model with virus diffusion and latently infected cell activation
- Hopf bifurcation in a CTL-inclusive HIV-1 infection model with two time delays
- Time periodic reaction-diffusion equations for modeling 2-LTR dynamics in HIV-infected patients
- Global dynamics of a delayed diffusive virus infection model with cell-mediated immunity and cell-to-cell transmission
- Modelling of HIV viral load and 2-LTR dynamics during high active antiretroviral therapy in a heterogeneous environment
- Towards a new combination therapy with vectored immunoprophylaxis for HIV: modeling ``Shock and kill strategy
- Modeling the role of macrophages in HIV persistence during antiretroviral therapy
- Stochastic perturbation to 2-LTR dynamical model in HIV infected patients
This page was built for publication: Influence of raltegravir intensification on viral load and 2-LTR dynamics in HIV patients on suppressive antiretroviral therapy
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2013422)
